Safety and efficacy of an outpatient 12-step desensitization protocol for antineoplastic agents.

Idil ErogluOlga T FilippovaMaria KirraneMary OrpenVianca AlmonteRachel ThomasMelissa Lee-TehRichard TizonNancy SklarinRoisin E O'Cearbhaill

Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2022)

Our outpatient 12-step, institutional desensitization protocol for antineoplastic therapy proved safe and efficacious, with 56% of patients successfully completing ≥3 cycles and not requiring an inpatient admission.

Keyphrases

end stage renal disease
randomized controlled trial
ejection fraction
newly diagnosed
chronic kidney disease
emergency department
peritoneal dialysis
prognostic factors
mental health
palliative care
stem cells
patient reported outcomes
cell therapy
acute care
replacement therapy